Once-weekly exenatide in type 2 diabetes

被引：0
|
作者：
Parmar, Dinesh M. [1 ]
Jadav, Shilpa P. [1 ]
机构：
[1] MP Shah Med Coll, Dept Pharmacol, Jamnagar, Gujarat, India
来源：
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES | 2011年 / 31卷 / 02期
关键词：
OPEN-LABEL;
D O I：
10.1007/s13410-011-0018-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：121 / 122
页数：2
相关论文
共 50 条
  • [21] Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada
    Johansen, Pierre
    Hakan-Bloch, Jonas
    Liu, Aiden R.
    Bech, Peter G.
    Persson, Sofie
    Leiter, Lawrence A.
    PHARMACOECONOMICS-OPEN, 2019, 3 (04) : 537 - 550
  • [22] Modeling Cardiovascular Health Outcomes Associated with Once-Weekly Exenatide Versus Traditional Therapies for Type 2 Diabetes
    Peskin, Barbara R.
    Shcheprov, Andrei V.
    Kalsekar, Anupama
    Boye, Kristina S.
    Bruce, Simon
    Gaebler, Julia A.
    DIABETES, 2010, 59 : A162 - A162
  • [23] Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes
    Arslanian, Silva A.
    Hannon, Tamara
    Zeitler, Philip
    Chao, Lily C.
    Boucher-Berry, Claudia
    Barrientos-Perez, Margarita
    Bismuth, Elise
    Dib, Sergio
    Cho, Jang Ik
    Cox, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (05): : 433 - 443
  • [24] Once-Weekly Dulaglutide for Treatment of Youths with Type 2 Diabetes
    Senoo, Yuki
    Kami, Masahiro
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (16): : 1529 - 1530
  • [25] Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial
    Ildiko Lingvay
    Malik Benamar
    Liming Chen
    Ariel Fu
    Esteban Jódar
    Tomoyuki Nishida
    Jean-Pierre Riveline
    Daisuke Yabe
    Thomas Zueger
    Rosângela Réa
    Diabetologia, 2025, 68 (4) : 739 - 751
  • [26] The efficacy and safety of exenatide once weekly in patients with type 2 diabetes
    Heimburger, Sebastian M.
    Bronden, Andreas
    Johansen, Nicklas J.
    Dejgaard, Thomas F.
    Vilsboll, Tina
    Knop, Filip K.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (05) : 501 - 510
  • [27] Comparison of once-weekly with twice-daily exenatide in the treatment of type 2 diabetes (DURATION-1 trial)
    Raskin, Philip
    Mohan, Alok
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (13) : 2269 - 2271
  • [28] Predictors of Glycemic and Weight Response to Exenatide Once-Weekly in Patients with Type 2 Diabetes in a Real-World Setting
    Gorgojo-Martinez, Juan J.
    Brito-Sanfiel, Miguel A.
    Gargallo-Fernandez, Manuel A.
    Lisbona-Catalan, Arturo
    DIABETES, 2017, 66 : A297 - A297
  • [29] Efficacy and Safety of Once-Weekly Semaglutide vs. Exenatide ER in Subjects with Type 2 Diabetes (SUSTAIN 3)
    Ahmann, Andrew J.
    Capehorn, Matthew
    Charpentier, Guillaume
    Dotta, Francesco
    Henkel, Elena
    Lingvay, Ildiko
    Holst, Anders Gaarsdal
    Chang, Denise
    Aroda, Vanita R.
    DIABETES, 2016, 65 : A49 - A49
  • [30] Effect of once-weekly exenatide on hospitalization for acute coronary syndrome or coronary revascularization in patients with type 2 diabetes mellitus
    Barbery, Carlos E.
    Giczewska, Anna
    White, Jennifer
    Lokhnygina, Yuliya
    Mentz, Robert John
    Holman, Rury R.
    Pagidipati, Neha
    Hernandez, Adrian F.
    Jones, W. Schuyler
    AMERICAN HEART JOURNAL, 2021, 239 : 59 - 63
12345